Flow Cytometry Markets: Global Analysis and Opportunity Evaluation 2016 - 2020

 
Customer Support
+44 (0)1487 843 722

If you have any questions regarding this
report, please call us on the number above.

Chat with the Author
Call +44 (0)7870 204 848
 
Untitled Document

1. Introduction (p37)

1.1 background
1.2 Flow Cytometry 2016
1.3 End-user Study

2. Global Regions (p61)

2.1 Global Flow Cytometry
2.2 All Global Regions
2.3 All Countries
2.4 North America
2.5 Europe
2.6 Asia
2.7 South America
2.8 Middle East
2.9 Oceania

3. Organisations (p72)

3.1 Global Flow Cytometry
3.2 All Global Regions
3.3 Asia
3.4 Europe
3.5 North America
3.6 South America
3.7 Middle East
3.8 Oceania

4. Department Types (p84)

4.1 Overview
4.2 All Global Regions
4.3 Asia
4.4 Europe
4.5 North America
4.6 South America
4.7 Middle East
4.8 Oceania

5. Flow Cytometry Methods (p114)

5.1 Global Flow Cytometry
5.2 All Global Regions
5.3 Asia
5.4 Europe
5.5 North America
5.6 South America
5.7 Middle East
5.8 Oceania

6. Flow Cytometry Applications (p120)

1 Overview
6.2 All Global Regions
6.3 Asia
6.4 Europe
6.5 North America
6.6 South America
6.7 Middle East
6.8 Oceania

7. Cell Types (p139)

7.1 Overview
7.2 All Global Regions
7.3 Asia
7.4 Europe
7.5 North America

8. Viruses (p147)

8.1 Overview
8.2 All Global Regions
8.3 Asia
8.4 Europe
8.5 North America

9. Bacteria (p154)

9.1 Overview
9.2 All Global Regions
9.2 Asia
9.4 Europe
9.5 North America

10. Diseases (p168)

10.1 Overview
10.2 All Global Regions
10.3 Asia
10.4 Europe
10.5 North America

11. CD Markers (p185)

11.1 Overview
11.2 All Global Regions
11.3 Asia
11.4 Europe
11.5 North America

12. Clinical or Other (p196)

12.1 Overview
12.2 All Global Regions
12.3 Asia
12.4 Europe
12.5 North America

13. Growth (p199)

14. End-user Study (p227)

15. Discussion (p351)

Figures

Figure 2.1 Flow Cytometry by Global Region
Figure 2.2 Flow Cytometry by Countries
Figure 2.3 Flow Cytometry in North America
Figure 2.3 Flow Cytometry in North America
Figure 2.4 Flow Cytometry in Europe
Figure 2.4 Flow Cytometry in Europe
Figure 2.4 Flow Cytometry in Europe
Figure 2.5 Flow Cytometry in Asia
Figure 2.5 Flow Cytometry in Asia
Figure 2.5 Flow Cytometry in Asia
Figure 2.6 Flow Cytometry in South America
Figure 2.6 Flow Cytometry in South America
Figure 2.7 Flow Cytometry in Middle East
Figure 2.7 Flow Cytometry in Middle East
Figure 2.7 Flow Cytometry in Middle East
Figure 2.8 Flow Cytometry in Oceania
Figure 2.8 Flow Cytometry in Cceania
Figure 3.1 Organisation types across all global regions
Figure 3.1 Organisation types across all global regions
Figure 3.1 Organisation types across all global regions
Figure 3.2 Organisation types in Asia
Figure 3.2 Organisation types in Asia
Figure 3.2 Organisation types in Asia
Figure 3.3 Organisation types in Europe
Figure 3.3 Organisation types in Europe
Figure 3.3 Organisation types in Europe
Figure 3.4 Organisation types in North America
Figure 3.4 Organisation types in North America
Figure 3.4 Organisation types in North America
Figure 3.5 Organisation types in South America
Figure 3.5 Organisation types in South America
Figure 3.6 Organisation types in the Middle East
Figure 3.6 Organisation types in the Middle East
Figure 3.7 Organisation types in the Oceania
Figure 3.7 Organisation types in Oceania
Figure 3.7 Organisation types in Oceania
Figure 4.1 Departments by all global regions
Figure 4.2 Departments in Asia
Figure 4.3 Departments in Europe
Figure 4.4 Departments in North America
Figure 4.5 Departments in South America
Figure 4.6 Departments in the Middle East
Figure 4.7 Departments in Oceania
Figure 5.1 Flow Cytometry by Global Region
Figure 5.2 Flow Cytometry by Global Region
Figure 5.3 Flow Cytometry by Global Region
Figure 5.4 Flow Cytometry by Global Region
Figure 5.5 Flow Cytometry by Global Region
Figure 5.6 Flow Cytometry by Global Region
Figure 5.7 Flow Cytometry by Global Region
Figure 6.1 Applications across all global regions.
Figure 6.2 Applications in Asia
Figure 6.3 Applications in Europe
Figure 6.4 Applications in North America
Figure 6.5 Applications in South America
Figure 6.6 Applications in the Middle East
Figure 6.7 Applications in the Oceania
Figure 7.1 Cell types studied across all global regions
Figure 7.2 Cell types studied in Asia
Figure 7.3 Cell types studied in Europe
Figure 7.4 Cell types studied in North America
Figure 8.1 Viruses studied across all global regions
Figure 8.2 Viruses studied in Asia
Figure 8.3 Viruses studied in Europe
Figure 8.4 Viruses studied in North America
Figure 9.1 Bacteria studied across all global regions
Figure 9.1 Bacteria studied in Asia
Figure 9.1 Bacteria studied in Asia
Figure 9.1 Bacteria studied in Asia
Figure 9.1 Bacteria studied in Asia
Figure 9.1 Bacteria studied in Europe
Figure 9.1 Bacteria studied in Europe
Figure 9.1 Bacteria studied in Europe
Figure 9.1 Bacteria studied in Europe
Figure 9.1 Bacteria studied in Europe
Figure 9.1 Bacteria studied in North America
Figure 9.1 Bacteria studied in North America
Figure 9.1 Bacteria studied in North America
Figure 9.1 Bacteria studied in North America
Figure 10.1 Diseases for all global regions
Figure 10.2 Diseases in Asia
Figure 10.3 Diseases in Europe
Figure 10.4 Diseases in North America
Figure 11.1 Flow Cytometry by Global Region
Figure 11.2 Flow Cytometry by Global Region
Figure 11.3 Flow Cytometry by Global Region
Figure 11.4 Flow Cytometry by Global Region
Figure 12.1 Clinical vs. other use, globally
Figure 12.2 Clinical vs. other use in Asia
Figure 12.3 Clinical vs. other use in Europe
Figure 12.4 Clinical vs. other use in North America
Figure 13.1 Growth of flow cytometry across in Asia 2013 to 2015
Figure 13.2 Growth of flow cytometry in Europe 2013 to 2015
Figure 13.3 Growth of flow cytometry in North America 2013 to 2015
Figure 13.4 Growth of flow cytometry in South America 2013 to 2015
Figure 13.5 Growth of flow cytometry in Middle East 2013 to 2015
Figure 13.6 Growth of flow cytometry in the Oceania 2013 to 2015
Figure 13.7 Growth of flow cytometry in Northern Africa 2013 to 2015
Figure 13.8 Growth of flow cytometry in Southern Africa 2013 to 2015
Figure 13.9 Growth of flow cytometry in Central America 2013 to 2015
Figure 13.10 Growth of flow cytometry in Eastern Africa 2013 to 2015
Figure 13.11 Growth of flow cytometry in China 2013 to 2015
Figure 13.12 Growth of flow cytometry in the United States 2013 to 2015
Figure 13.13 Growth of flow cytometry in Germany 2013 to 2015
Figure 13.14 Growth of flow cytometry in Japan 2013 to 2015
Figure 13.15 Growth of flow cytometry in United Kingdom 2013 to 2015
Figure 13.16 Growth of flow cytometry in Italy 2013 to 2015
Figure 13.17 Growth of flow cytometry in India 2013 to 2015
Figure 13.18 Growth of flow cytometry in France 2013 to 2015
Figure 13.19 Growth of flow cytometry in Spain 2013 to 2015
Figure 13.20 Growth of flow cytometry in Brazil 2013 to 2015
Figure 13.21 Growth of flow cytometry 2013 to 2015
Figure 13.22 Growth of FACS 2013 to 2015
Figure 13.23 Growth of Cytometric Bead Array 2013 to 2015
Figure 13.24 Growth of imaging flow cytometry 2013 to 2015
Figure 13.25 Growth of Apoptosis applications 2013 to 2015
Figure 13.26 Growth of gene expression applications 2013 to 2015
Figure 13.27 Growth of cytokines applications 2013 to 2015
Figure 13.28 Growth of cell cycle applications 2013 to 2015
Figure 13.29 Growth of cell sorting applications 2013 to 2015
Figure 13.30 Growth of T-cell applications 2013 to 2015
Figure 13.31 Growth of cell proliferation applications 2013 to 2015
Figure 13.32 Growth of cell counting applications 2013 to 2015
Figure 13.33 Growth of immune monitoring applications 2013 to 2015
Figure 13.34 Growth of cell activation applications 2013 to 2015
Figure 13.35 Growth of breast cancer applications 2013 to 2015
Figure 13.36 Growth of leukaemia applications 2013 to 2015
Figure 13.37 Growth of liver cancer applications 2013 to 2015
Figure 13.38 Growth of lymphoma applications 2013 to 2015
Figure 13.39 Growth of rectal cancer applications 2013 to 2015
Figure 13.40 Growth of prostate cancer applications 2013 to 2015
Figure 13.41 Growth of gastric cancer applications 2013 to 2015
Figure 13.42 Growth of squamous cell carcinoma 2013 to 2015
Figure 13.43 Growth of lung cancer applications 2013 to 2015
Figure 13.44 Growth of glioma applications 2013 to 2015
Figure 13.45 Growth of B lymphocyte cell studies 2013 to 2015
Figure 13.46 Growth of lymphocyte cell studies 2013 to 2015
Figure 13.47 Growth of endothelial cell studies 2013 to 2015
Figure 13.48 Growth of macrophage cell studies 2013 to 2015
Figure 13.49 Growth of dendritic cell studies 2013 to 2015
Figure 13.50 Growth of epithelial cell studies 2013 to 2015
Figure 13.51 Growth of platelet cell studies 2013 to 2015
Figure 13.52 Growth of monocyte cell studies 2013 to 2015
Figure 13.53 Growth of T-cell studies 2013 to 2015
Figure 13.54 Growth of fibroblasts 2013 to 2015
Figure 13.55 Growth of CD8 studies 2013 to 2015
Figure 13.56 Growth of CD4 studies 2013 to 2015
Figure 13.57 Growth of CD8+ studies 2013 to 2015
Figure 13.58 Growth of CD45 studies 2013 to 2015
Figure 13.59 Growth of CD4+ studies 2013 to 2015
Figure 13.60 Growth of CD7 studies 2013 to 2015
Figure 13.61 Growth of CD34 studies 2013 to 2015
Figure 13.62 Growth of CD14 studies 2013 to 2015
Figure 13.63 Growth of CD5 studies 2013 to 2015
Figure 13.64 Growth of CD56 studies 2013 to 2015
Figure 13.64 Growth of Hepatitis studies 2013 to 2015
Figure 13.64 Growth of HIV studies 2013 to 2015
Figure 13.64 Growth of Influenza A 2013 to 2015
Figure 13.64 Growth of Escherichia coli studies 2013 to 2015
Figure 13.64 Growth of Staphylococcus aureus 2013 to 2015
Figure 13.64 Growth of Mycobacterium tuberculosis studies 2013 to 2015
Figure 2.1. Global regions of participants in FC2015
Figure 2.2. Top 10 countries of participants in FC2015
Figure 2.3. Top ten job titles of participants in FC2015
Figure 2.4. Top ten experience levels of participants in FC2015
Figure 2.5. Organisation types of participants in FC2015
Figure 2.6. Professional roles of participants in FC2015
Figure 2.7. Main flow cytometry activities of participants FC2015
Figure 3.1. Top ten fields of participants in FC2015
Figure 4.1. Top ten current broad flow
Figure 4.2. Top ten future broad flow
Figure 5.1. Main areas of flow cytometry of participants in FC2015
Figure 6.1. Main flow cytometry activities
Figure 6.2. Top ten current main samples analysed
Figure 6.3. Top ten anticipated future main samples to be analysed
Figure 6.4. Top ten current diseases relating to their
Figure 6.5. Top ten anticipated future diseases relating to their
Figure 6.6. Top ten current general applications relating to
Figure 6.7. Top ten anticipated future general applications relating to
Figure 6.8. Top ten current clinical applications relating to
Figure 6.9. Top ten future clinical applications relating to
Figure 6.10. Top ten current instrument suppliers relating to
Figure 6.12. Current instrument suppliers relating to their
Figure 6.12. Current instrument suppliers relating to their
Figure 6.11. Top ten anticipated future instrument suppliers relating to
Figure 6.12. Top ten current flow cytometry instruments in
Figure 6.13. Top ten future flow cytometry instruments in
Figure 6.14. Top ten innovation and development requirements in
Figure 6.15. Top ten current consumables suppliers relating to
Figure 6.16. Top ten future consumables suppliers relating to
Figure 6.17. Top ten sample preparation steps and methods
Figure 6.18. Top ten flow cytometry software types used in
Figure 6.19. Top ten numbers of colours used now in their
Figure 6.20. Top ten maximum numbers of colours used so far
Figure 6.21. Top ten numbers of colours expected to
Figure 7.1. Main flow cytometry activities
Figure 7.2. Top ten current main samples analysed
Figure 7.3. Top ten anticipated future main samples analysed
Figure 7.3. Anticipated future main samples analysed using
Figure 7.3. Anticipated future main samples analysed using
Figure 7.4. Top ten current diseases relating to their
Figure 7.5. Top ten anticipated future diseases relating to their
Figure 7.6. Top ten current general applications relating to
Figure 7.7. Top ten anticipated future general applications relating to
Figure 7.8. Top ten current clinical applications relating to
Figure Table 7.9. Current clinical applications relating to
Figure Table 7.9. Current clinical applications relating to
Figure Table 7.9. Current clinical applications relating to
Figure Table 7.9. Current clinical applications relating to
Figure 7.9. Top ten anticipated future clinical applications relating to
Figure 7.10. Top ten current instrument suppliers relating to
Figure 7.11. Top ten anticipated future instrument suppliers relating to
Figure 7.12. Top ten current flow cytometry instruments
Figure 7.13. Top ten anticipated future flow cytometry instruments in
Figure 7.14. Innovation and development requirements in
Figure 7.15. Top ten current consumables suppliers relating to
Figure 7.16. Top ten anticipated future consumables suppliers relating to
Figure 7.17. Top ten sample preparation steps and methods used
Figure 7.18. Top ten flow cytometry software types used in
Figure 6.19. Top ten numbers of colours used now in their
Figure 7.20. Top ten maximum numbers of colours used so far
Figure 7.21. Top ten numbers of colours expected to
Figure 8.1. Top ten recent growth trends in their flow
Figure 8.2. Top ten anticipated future growth trends in their flow
Figure 10.1. Top ten flow cytometry sample
Figure 11.1. Top ten monthly flow cytometry
Figure 11.3. Monthly flow cytometry sample

Tables

Table 2.1 Flow Cytometry by Global Region
Table 2.1 Flow Cytometry by Global Region
Table 2.2 Flow Cytometry by Countries
Table 2.2 Flow Cytometry by Countries
Table 2.2 Flow Cytometry by Countries
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.1 Departments by all global regions
Table 4.2 Departments in Asia
Table 4.2 Departments in Asia
Table 4.2 Departments in Asia
Table 4.2 Departments in Asia
Table 4.2 Departments in Asia
Table 4.2 Departments in Asia
Table 4.3 Departments in Europe
Table 4.3 Departments in Europe
Table 4.3 Departments in Europe
Table 4.3 Departments in Europe
Table 4.3 Departments in Europe
Table 4.3 Departments in Europe
Table 4.4 Departments in North America
Table 4.4 Departments in North America
Table 4.4 Departments in North America
Table 4.5 Departments in South America
Table 4.5 Departments in South America
Table 4.6 Departments in the Middle East
Table 4.6 Departments in the Middle East
Table 4.6 Departments in the Middle East
Table 4.7 Departments in Oceania
Table 4.7 Departments in Oceania
Table 5.1 Flow Cytometry by Global Region
Table 5.2 Flow Cytometry by Global Region
Table 5.3 Flow Cytometry by Global Region
Table 5.4 Flow Cytometry by Global Region
Table 5.5 Flow Cytometry by Global Region
Table 5.6 Flow Cytometry by Global Region
Table 5.7 Flow Cytometry by Global Region
Table 6.1 Applications across all global regions
Table 6.1 Applications across all global regions
Table 6.1 Applications across all global regions
Table 6.2 Applications in Asia
Table 6.2 Applications in Asia
Table 6.2 Applications in Asia
Table 6.3 Applications in Europe
Table 6.3 Applications in Europe
Table 6.3 Applications in Europe
Table 6.4 Applications in North America
Table 6.4 Applications in North America
Table 6.4 Applications in North America
Table 6.5 Applications in South America
Table 6.5 Applications in South America
Table 6.5 Applications in South America
Table 6.6 Applications in the Middle East
Table 6.6 Applications in the Middle East
Table 6.7 Applications in the Oceania
Table 6.7 Applications in the Oceania
Table 7.1 Cell types studied across all global regions
Table 7.1 Cell types studied across all global regions
Table 7.2 Cell types studied in Asia
Table 7.2 Cell types studied in Asia
Table 7.3 Cell types studied in Europe
Table 7.3 Cell types studied in Europe
Table 7.4 Cell types studied in North America
Table 7.4 Cell types studied in North America
Table 8.1 Viruses studied across all global regions
Table 8.1 Viruses studied across all global regions
Table 8.2 Viruses studied in Asia
Table 8.3 Viruses studied in Europe
Table 8.3 Viruses studied in Europe
Table 8.4 Viruses studied in North America
Table 8.4 Viruses studied in North America
Table 9.1 Bacteria studied across all global regions
Table 9.1 Bacteria studied across all global regions
Table 9.1 Bacteria studied across all global regions
Table 9.1 Bacteria studied across all global regions
Table 10.1 Diseases for all global regions
Table 10.1 Diseases for all global regions
Table 10.1 Diseases for all global regions
Table 10.1 Diseases for all global regions
Table 10.2 Diseases in Asia
Table 10.2 Diseases in Asia
Table 10.2 Diseases in Asia
Table 10.2 Diseases in Asia
Table 10.3 Diseases in Europe
Table 10.3 Diseases in Europe
Table 10.3 Diseases in Europe
Table 10.3 Diseases in Europe
Table 10.4 Diseases in North America
Table 10.4 Diseases in North America
Table 10.4 Diseases in North America
Table 10.4 Diseases in North America
Table 11.1 Flow Cytometry by Global Region
Table 11.1 Flow Cytometry by Global Region
Table 11.1 Flow Cytometry by Global Region
Table 11.2 Flow Cytometry by Global Region
Table 11.2 Flow Cytometry by Global Region
Table 11.3 Flow Cytometry by Global Region
Table 11.3 Flow Cytometry by Global Region
Table 11.3 Flow Cytometry by Global Region
Table 11.4 Flow Cytometry by Global Region
Table 11.4 Flow Cytometry by Global Region
Table 11.4 Flow Cytometry by Global Region
Table 13.1 Growth in the flow cytometry market
Table 13.1 Growth in the flow cytometry market
Table 13.1 Growth in the flow cytometry market
Table 2.1. Global regions of participants in FC2015
Table 2.2. Countries of participants in FC2015
Table 2.2. Countries of participants in FC2015
Table 2.3. Job titles of participants in FC2015
Table 2.3. Job titles of participants in FC2015
Table 2.3. Job titles of participants in FC2015
Table 2.3. Job titles of participants in FC2015
Table 2.4. Experience levels of participants in FC2015
Table 2.4. Experience levels of participants in FC2015
Table 2.5. Organisation types of participants in FC2015
Table 2.6. Professional roles of participants in FC2015
Table 2.7. Main flow cytometry activities of participants FC2015
Table 3.1. Fields of participants in FC2015
Table 3.1. Fields of participants in FC2015
Table 4.1. Current broad flow cytometry
Table 4.2. Future broad flow cytometry
Table 4.2. Future broad flow cytometry
Table 4.3. Comparative analysis of current and future main
Table 5.1 Main areas of flow cytometry of participants in FC2015
Table 6.1. Main flow cytometry activities
Table 6.2. Current main samples analysed using
Table 6.2. Current main samples analysed using
Table 6.3. Anticipated future main samples analysed using
Table 6.3. Anticipated future main samples analysed using
Table 6.4. Current diseases relating to their use of
Table 6.4. Current diseases relating to their use of
Table 6.5. Anticipated future diseases relating to their
Table 6.5. Anticipated future diseases relating to their
Table 6.6. Current general applications relating to their
Table 6.6. Current general applications relating to their
Table 6.7. Anticipated future general applications relating to
Table 6.7. Anticipated future general applications relating to
Table 6.8. Comparative analysis of current and future
Table 6.8. Comparative analysis of current and future
Table 6.9. Current clinical applications relating to their
Table 6.9. Current clinical applications relating to their
Table 6.9. Current clinical applications relating to their
Table 6.9. Current clinical applications relating to their
Table 6.10. Future anticipated clinical applications relating to
Table 6.10. Future anticipated clinical applications relating to
Table 6.10. Future anticipated clinical applications relating to
Table 6.11. Comparative analysis of current and future
Table 6.11. Comparative analysis of current and future
Table 6.11. Comparative analysis of current and future
Table 6.11. Comparative analysis of current and future
Table 6.13. Anticipated future instrument suppliers relating to
Table 6.14. Comparative analysis of current and future suppliers of
Table 6.15. Current flow cytometry instruments in
Table 6.15. Current flow cytometry instruments in
Table 6.15. Current flow cytometry instruments in
Table 6.16. Anticipated future flow cytometry instruments in
Table 6.16. Anticipated future flow cytometry instruments in
Table 6.17. Innovation and development requirements in
Table 6.17. Innovation and development requirements in
Table 6.17. Innovation and development requirements in
Table 6.18. Current consumables suppliers relating to their
Table 6.18. Current consumables suppliers relating to their
Table 6.19. Anticipated future consumables suppliers relating to
Table 6.19. Anticipated future consumables suppliers relating to
Table 6.20. Comparative analysis of current and future of
Table 6.20. Comparative analysis of current and future of
Table 6.20. Comparative analysis of current and future of
Table 6.21. Sample preparation steps and methods used
Table 6.21. Sample preparation steps and methods used
Table 6.22. Flow cytometry software types used in their
Table 6.22. Flow cytometry software types used in their
Table 6.23. Numbers of colours used now in their
Table 6.24. Maximum numbers of colours used so far
Table 6.25. Top ten numbers of colours expected to
Table 7.1. Main flow cytometry activities
Table 7.2. Current main samples analysed using
Table 7.2. Current main samples analysed using
Table 7.4. Current diseases relating to their use
Table 7.4. Current diseases relating to their use
Table 7.5. Anticipated future diseases relating to their use of
Table 7.5. Anticipated future diseases relating to their use of
Table 7.6. Current general applications relating to their
Table 7.6. Current general applications relating to their
Table 7.7. Anticipated future general applications relating to their
Table 7.7. Anticipated future general applications relating to their
Table 7.8. Comparative analysis of current and future
Table 7.8. Comparative analysis of current and future
Table 7.10. Anticipated future clinical applications relating to
Table 7.10. Anticipated future clinical applications relating to
Table 7.10. Anticipated future clinical applications relating to
Table 7.10. Anticipated future clinical applications relating to
Table 7.11. Comparative analysis of current and future
Table 7.11. Comparative analysis of current and future
Table 7.11. Comparative analysis of current and future
Table 7.11. Comparative analysis of current and future
Table 7.12. Current instrument suppliers relating to their
Table 7.12. Current instrument suppliers relating to their
Table 7.13. Anticipated future instrument suppliers relating to
Table 7.14. Comparative analysis of current and future suppliers
Table 7.15. Current flow cytometry instruments in
Table 7.15. Current flow cytometry instruments in
Table 7.16. Anticipated future flow cytometry instruments in
Table 7.16. Anticipated future flow cytometry instruments in
Table 7.17. Innovation and development requirements in
Table 7.17. Innovation and development requirements in
Table 7.17. Innovation and development requirements in
Table 7.18. Current consumables suppliers relating to
Table 7.18. Current consumables suppliers relating to
Table 7.19. Anticipated future consumables suppliers relating to
Table 7.19. Anticipated future consumables suppliers relating to
Table 7.20. Comparative analysis of current and future of flow
Table 7.20. Comparative analysis of current and future of flow
Table 7.21 Sample preparation steps and methods used
Table 7.21 Sample preparation steps and methods used
Table 7.22. Flow cytometry software types used in
Table 7.22. Flow cytometry software types used in
Table 8.1. Recent growth trends in their flow
Table 8.1. Recent growth trends in their flow
Table 8.2. Anticipated future growth trends in their flow
Table 8.2. Anticipated future growth trends in their flow
Table 10.1. Flow cytometry sample